Bienvenido, invitado! | iniciar la sesión
US ES

Activity Stream

MoatRx
@moatrx2 weeks ago
Posted a new blog:
US COLD AGGLUTININ DISEASE LAUNCH READINESS
Sutimlimab left 46 percent of trial patients without a hemoglobin response, yet two rival complement programs abandoned the disease after its launch. Sutimlimab...

Tags

Dislike 0
MoatRx
Seguidores:
bestcwlinks willybenny01 beejgordy quietsong vigilantcommunications avwanthomas audraking askbarb artisticsflix artisticflix aanderson645 arojo29 anointedhearts annrule rsacd
Recientemente clasificados:
estadísticas
Blogs: 120